Parkinson’s disease

Still openEvidence checked

Subjects: Disease mechanisms · Brain and cognition

Reading depth

The problem

Walking and other everyday movements can become difficult in Parkinson’s. Among the damaged brain cells are those that produce dopamine, a chemical messenger used in movement. Yet some types are lost more readily than others. What makes them especially vulnerable, and how do inherited differences, surroundings and failures inside the cells combine to damage them?[1] [2]

Scope

The causal mechanisms of Parkinson’s disease, including protein handling, vulnerable neurons, genetic factors, environmental contributions, and disease heterogeneity.

What remains open

Inherited causes and important cell processes are known. Most cases still lack one complete explanation.[1]

Why it matters

A cell must keep working while also maintaining its parts. Understanding why that maintenance fails in particular cells connects a microscopic process to a person’s difficulty moving. It also explains why sharing the job of producing dopamine does not necessarily give two cells the same vulnerability.[1] [2] [3]

Definitions

3 terms
Dopamine

A chemical messenger used by nerve cells. Loss of dopamine-producing cells in a particular brain region contributes to Parkinson’s movement problems.[1]

Lysosome

A compartment in a cell that uses enzymes to break down and recycle materials. Its failure is one studied contributor to problems with cellular maintenance.[1] [3]

Mitochondria

Structures within a cell that help produce usable energy. The page discusses chemical stress in these structures in experimental dopamine-producing cells.[1] [3]

Sources

  1. Parkinson's Disease National Institute of Neurological Disorders and Stroke
    Notes on Parkinson's Disease

    NINDS describes dopamine-related movement problems and known genetic, protein-handling and cell-maintenance contributions. Fresh access was indexed primary text, and the account remains incomplete across common disease.

  2. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease Tushar Kamath, Abdulraouf Abdulraouf and colleagues · 2022-05-05
    Notes on Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease

    Primary postmortem study identifies an AGTR1-marked dopamine-cell population especially susceptible to loss. It provides a bounded clue to selective vulnerability, not proof that AGTR1 causes death or an explanation of every symptom.

  3. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease Lena F. Burbulla and colleagues · 2017-09-07
    Notes on Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

    Primary experimental cell study connects mitochondrial stress, dopamine oxidation, lysosomal dysfunction and alpha-synuclein accumulation. Its human-derived and mouse model comparison is bounded to tested conditions, not a sequence established in every patient.

Suggest a correction